Evidence map›Paper›PMID 40366653›Full record

ArticleJAMA network open2025

Cannabis Use Among Older Adults.

Vira Pravosud, Emily Lum, Marzieh Vali, Beth E Cohen, Katherine J Hoggatt, Amy L Byers, Peter C Austin, Louise C Walter, Deborah Hasin, Tauheed Zaman and 1 more

Abstract read
In one paragraph

Article in JAMA network open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Cannabinoid neuropharmacology across the lifespan: how aging recalibrates risk and benefit.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Vira PravosudCenter for Data to Discovery and Delivery Innovation, San Francisco Veterans Affairs (VA) Health Care System, San Francisco, California.
Emily LumCenter for Data to Discovery and Delivery Innovation, San Francisco Veterans Affairs (VA) Health Care System, San Francisco, California.
Marzieh ValiCenter for Data to Discovery and Delivery Innovation, San Francisco Veterans Affairs (VA) Health Care System, San Francisco, California.
Beth E CohenCenter for Data to Discovery and Delivery Innovation, San Francisco Veterans Affairs (VA) Health Care System, San Francisco, California.
Katherine J HoggattCenter for Data to Discovery and Delivery Innovation, San Francisco Veterans Affairs (VA) Health Care System, San Francisco, California.
Amy L ByersCenter for Data to Discovery and Delivery Innovation, San Francisco Veterans Affairs (VA) Health Care System, San Francisco, California.
Peter C AustinInstitute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
Louise C WalterSchool of Medicine, University of California, San Francisco.
Deborah HasinDepartment of Psychiatry, Columbia University Medical Center, New York, New York.
Tauheed ZamanDepartment of Psychiatry and Behavioral Sciences, University of California, San Francisco.
Salomeh KeyhaniCenter for Data to Discovery and Delivery Innovation, San Francisco Veterans Affairs (VA) Health Care System, San Francisco, California.

Funding

Impact of Medical and Recreational Marijuana Laws On Cannabis, Opioids And Psychiatric Medications: National Study of VA Patients, 2000 - 2024R01DA048860 · NIDA · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI HASIN, DEBORAH S · 2019 to 2023
$4.1M
Marijuana Use in Older Adults: Health, Function and Fall-Related InjuryR01AG058678 · NIA · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI KEYHANI, SALOMEH · 2019 to 2023
$3.0M
Risk Thresholds of Alcohol and Polysubstance Use Among Older AdultsR56AG070204 · NIA · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI HOGGATT, KATHERINE JOANN · 2021 to 2021
$694k
CSRD VA IK6 CX002386NIA NIH HHS R01 AG058678NIA NIH HHS R56 AG070204NIDA NIH HHS R01 DA048860
6 · The paper itself

Abstract

Importance: Little is known about patterns (forms, frequency, and reasons) and factors associated with cannabis use in older veterans (aged ≥65 years). Objective: To examine factors associated with past 30-day cannabis use and cannabis use disorder (CUD) in older veterans. Design, Setting, and Participants: In this cross-sectional study, community-dwelling adults aged 65 to 84 years who used Veterans Health Administration care were interviewed between February 5, 2020, and August 29, 2023. Exposure: Sociodemographic, behavioral, and health-related characteristics. Main Outcomes and Measures: Past 30-day cannabis use (smoking, vaping, dabbing, or edibles) and any CUD (≥2 criteria based on Diagnostic and Statistical Manual of Mental Disorders [Fifth Edition]) were assessed using weighted multivariable logistic regressions. Results: Of the 4503 participants (weighted mean age, 73.3 years [95% CI, 73.0-73.5 years]; 85.4% [95% CI, 83.6%-87.2%] men), 58.2% (95% CI, 55.3%-61.0%) had ever used cannabis, 28.9% (95% CI, 26.0%-31.8%) of whom reported using cannabis for medical reasons, most commonly for pain (56.4%; 95% CI, 50.9%-61.9%), mood or mental health (18.4%; 95% CI, 14.7%-22.1%), and sleep (16.0%; 95% CI, 11.9%-20.0%). More than 1 in 10 reported past 30-day cannabis use (10.3%; 95% CI, 8.9%-11.7%), with 52.4% (95% CI, 45.4%-59.4%) of these using cannabis for 20 days or more; smoking (72.4%; 95% CI, 65.4%-79.3%) and edibles (36.9%; 95% CI, 29.8%-43.9%) were the most common forms of use. Characteristics associated with past 30-day use included younger age (65-75 years), economic hardship, tobacco and illicit drug use, and residing in a state with recreationally legal cannabis. Among those with past 30-day cannabis use, 36.3% (95% CI, 30.1%-42.6%) screened positive for CUD, with higher odds among younger respondents, those reporting anxiety, those with 1 or more deficits in activities of daily living, those with illicit drug use, those with frequent cannabis use, and those using cannabis recreationally. Past 30-day inhaled cannabis use, compared with edibles only, was associated with increased odds of any CUD (adjusted odds ratio, 3.56; 95% CI, 1.12-11.26). Conclusions and Relevance: In this cross-sectional study of cannabis use in older veterans, use was common, and more than one-third who used in the past 30 days had any CUD. The prevalence of past 30-day cannabis use was close to tobacco use prevalence, and risk factors for cannabis use were similar to those observed in other populations. Frequent and inhaled cannabis use was associated with higher odds of any CUD. Routine health screening for cannabis use in Veterans Health Administration clinical settings is necessary to identify older adults with cannabis use.

Indexed as

Marijuana AbuseMarijuana UseVeteransAgedAged, 80 and overCross-Sectional StudiesFemaleHumansMaleUnited States

Identifiers

PMID40366653
PMCPMC12079303

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.